These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Is the use of Ro 10-9359 (Tigason) in children justified?
    Author: van der Rhee HJ, van Gelderen HH, Polano MK.
    Journal: Acta Derm Venereol; 1980; 60(3):274-5. PubMed ID: 6158237.
    Abstract:
    In 5 children ranging in age from 8 to 12 years, treatment with Ro 10-9359 for either psoriasis or erythrokeratodermia variabilis for periods of between 11 and 17 months did not cause marked growth retardation and gave excellent therapeutic results.
    [Abstract] [Full Text] [Related] [New Search]